| TCM | traditional Chinese medicine |
| HCC | hepatocellular carcinoma |
| TME | tumor microenvironment |
| TAM | tumor-associated macrophage |
| ROS | reactive oxygen species |
| CVDs | cardiovascular diseases |
| H/R | hypoxia/reoxygenation |
| IR | ischemia–reperfusion |
| Ang II | angiotensin II |
| AAC | abdominal aortic constriction |
| VSMCs | vascular smooth muscle cells |
| PDGF | platelet-derived growth factor |
| VEGF | vascular endothelial growth factor |
| VDCCs | voltage-dependent Ca2+ channels |
| BK | large-conductance Ca2+-activated channels |
| BBB | Blood–brain barrier |
| NMDA | N-methyl-d-aspartate |
| NOS | nitric oxide synthase |
| GS | glutamine synthetase |
| pMCAO | permanent middle cerebral artery occlusion |
| TNFα | tumor necrosis factor α |
| AD | Alzheimer’s disease |
| PD | Parkinson’s disease |
| CNS | central nervous system. |
| BSCB | blood–spinal cord barrier |
| PPAR | peroxisome proliferator-activated receptor |
| T2DM | type 2 diabetes mellitus |
| NAFLD | non-alcoholic fatty liver disease |
| SREBP-1c | sterol-CoA response element binding protein-1c |
| AMPK | AMP-activated protein kinase |
| HFD | high-fat diet |
| CPT1 | carnitine palmitoyl-transferase1 |
| GLUT4 | glucose transporter isoform 4 |
| DARTS | drug affinity responsive target stability |